Lv52
935 积分 2021-06-01 加入
In vivo engineering broadens CAR-T cell therapy use
2天前
求助中
The complete amino-acid sequence of a canine MU chain
10天前
已完结
Amino Acid Sequence of the Fc Region of a Canine Immunoglobulin M: Interspecies Homology for the IgM Class
10天前
已完结
CD55 is a key complement regulatory protein that counteracts complement-mediated inactivation of Newcastle Disease Virus
12天前
已完结
Quadruple adenine base–edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease–engineered T cells
13天前
已完结
Allogeneic CAR T cells: A new player in the field and the peculiar opportunities of the hospital exemption path
13天前
已完结
Benefit from huCAR19-IL18 cells in patients with CD19+ lymphomas after CAR T cells
13天前
已完结
A novel CD3ε fusion receptor allows use of T-cell engagers on TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape
13天前
已完结
Phase 1/2 Trial of Anti-CD7 Allogeneic WU-CART-007 in patients with Relapsed/Refractory T-cell Malignancies
13天前
已完结
Interleukin-enhanced CAR-engineered immune cells in tumor immunotherapy: current insights and future perspectives
13天前
已完结
皖公网安备34019202002308
